MedPath

Biliary decompression by new-type slim metal stents for unresectable malignant hilar biliary obstruction: multicenter prospective observational study

Not Applicable
Conditions
unresectable malignant hilar biliary obstruction
Registration Number
JPRN-UMIN000039752
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Thirteen of 14 patients were successfully implanted: 11 by side-by-side technique; 2 by stent-in-stent technique. During the observation period of 286 days (5-727 days), recurrent biliary obstruction (RBO) occurred in 69.2% of patients, and the median time to RBO was 177 days. Compared with previous reports, the results were generally comparable.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1) Upper gastrointestinal surgical reconstruction except for Billroth-I anastmosis 2) Scheduled for curative resection of malignant hilar biliary disease 3) After biliary stenting with unremovable biliary stent 4) Necessary for biliary stenting across the major papilla 5) ASA class 4 or more 6) Severe comorbidity/active infection/PSC/PBC/IgG4-SC 7) Judgement by the primary doctor or the medical team

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patency of new-type stents 6 months after stent placetment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath